SCHEMBL26420404

SCHEMBL26420404

Cc1ccc2[nH]nc(Cl)c2c1C(C)(C)Cc1cc(F)c(C(C)(C)C)c2cn[nH]c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22328050 0.73 MAPK1 (0.33) —
SCHEMBL24854231 0.72 — —
SCHEMBL24089317 0.67 — —
SCHEMBL25477205 0.67 GAA (0.31) —
SCHEMBL24854355 0.66 JAK2 (0.31) —
SCHEMBL18408609 0.63 — —
SCHEMBL22328049 0.62 METAP2 (0.33) —
SCHEMBL17030758 0.62 MAPK1 (0.33) —
SCHEMBL25799614 0.62 CYP1A2 (0.32) —
SCHEMBL17030759 0.62 IDO1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128824-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUND Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-04-27 — — US disclosed
Send feedback